Corn Growers Encouraged to Complete USDA Surveys

Aug 23, 2022

By Bryan Goodman

The National Corn Growers Association (NCGA) encourages growers to complete the following upcoming surveys:

Now – through Early September… 5 NASS’s Conservation Practice Adoption Motivations survey

No one knows the story of conservation in U.S. ag better than farmers and ranchers. Survey data will guide the implementation of USDA’s Natural Resources Conservation Service programs in the future. Respond online at www.agcounts.usda.gov.

In the mail… September Grain Stocks Report

Grain Stocks Report survey is in the mail. Survey data help the industry evaluate export potential and calculate supply of the crops available for the marketing year. You can respond securely online at www.agcounts.usda.gov. This survey collects information on stocks of whole grains and oilseeds stored off-farm as of Sept. 1.

Coming in November… The Census of Agriculture

Farmers are encouraged to take part in the Census of Agriculture in November. The Census of Agriculture is a complete count of U.S. farms, ranches and the people who operate them. It is the only source of uniform, comprehensive and impartial agriculture data for every county and state in the nation.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.